FR2614315B2 - Application de la proteine antigenique p28 a titre d'agent presentant une activite glutathion-s-transferase. - Google Patents

Application de la proteine antigenique p28 a titre d'agent presentant une activite glutathion-s-transferase.

Info

Publication number
FR2614315B2
FR2614315B2 FR878705691A FR8705691A FR2614315B2 FR 2614315 B2 FR2614315 B2 FR 2614315B2 FR 878705691 A FR878705691 A FR 878705691A FR 8705691 A FR8705691 A FR 8705691A FR 2614315 B2 FR2614315 B2 FR 2614315B2
Authority
FR
France
Prior art keywords
glutathion
agent
application
transferase activity
antigenic protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR878705691A
Other languages
English (en)
Other versions
FR2614315A2 (fr
Inventor
Paul Sondermeyer
Jean-Marc Balloul
Raymond Pierce
Jean-Marie Grzych
Marie-Paule Kieny
Gerard Loison
Andre Capron
Jean-Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR878705691A priority Critical patent/FR2614315B2/fr
Priority to AU77170/87A priority patent/AU613583B2/en
Priority to DE3788852T priority patent/DE3788852T2/de
Priority to ES87401915T priority patent/ES2061521T3/es
Priority to CA000545007A priority patent/CA1340839C/fr
Priority to EP87401915A priority patent/EP0268501B1/fr
Priority to AT87401915T priority patent/ATE100493T1/de
Priority to PH35714A priority patent/PH31198A/en
Priority to DK198704380A priority patent/DK173779B1/da
Priority to JP62209104A priority patent/JP3127261B2/ja
Priority to KR870009208A priority patent/KR880002894A/ko
Priority to CN198787106696A priority patent/CN87106696A/zh
Publication of FR2614315A2 publication Critical patent/FR2614315A2/fr
Application granted granted Critical
Publication of FR2614315B2 publication Critical patent/FR2614315B2/fr
Priority to US07/964,471 priority patent/US5597570A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
FR878705691A 1986-08-22 1987-04-22 Application de la proteine antigenique p28 a titre d'agent presentant une activite glutathion-s-transferase. Expired - Lifetime FR2614315B2 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR878705691A FR2614315B2 (fr) 1987-04-22 1987-04-22 Application de la proteine antigenique p28 a titre d'agent presentant une activite glutathion-s-transferase.
AU77170/87A AU613583B2 (en) 1986-08-22 1987-08-18 Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity
ES87401915T ES2061521T3 (es) 1986-08-22 1987-08-20 Proteinas con actividad glutation-s-transferasa, secuencias de adn, anticuerpos, poxvirus y medicamentos para la prevencion de la equistosomiasis.
CA000545007A CA1340839C (fr) 1986-08-22 1987-08-20 Proteines et leurs procede de preparation, sequences d'adn, anticorps et leur application, poxvirus, cellules transformees ou infectees, compositions pharmaceutiques utiles dans la prevention de la schistosomose et applications a titre d'agent presentant une activite glutathion-s-transferase
EP87401915A EP0268501B1 (fr) 1986-08-22 1987-08-20 Protéines à activité glutathion-S-transférase, séquences d'ADN, anticorps, poxvirus et médicaments pour la prévention de la schistosomose
AT87401915T ATE100493T1 (de) 1986-08-22 1987-08-20 Proteine mit glutathion-s-transferase-aktivitaet, dna-sequenzen, antikoerper, poxviren und arzneimittel zur praevention von schistosomiasis.
DE3788852T DE3788852T2 (de) 1986-08-22 1987-08-20 Proteine mit Glutathion-S-Transferase-Aktivität, DNA-Sequenzen, Antikörper, Poxviren und Arzneimittel zur Prävention von Schistosomiasis.
DK198704380A DK173779B1 (da) 1986-08-22 1987-08-21 Schistosomprotein, DNA-fragment kodende for proteinet, ekspressionsenhed og viral vektor indeholdende DNA-fragmentet, celle transformeret med ekspressionsenheden, farmaceutisk præparat indeholdende proteinet eller vektoren, anvendelse af proteinet
PH35714A PH31198A (en) 1986-08-22 1987-08-21 Protein recognized by antibodies raised against native P28 of schitosoma mansoni.
JP62209104A JP3127261B2 (ja) 1986-08-22 1987-08-21 蛋白質及びその製法、dna配列、抗体及びその用途、ポックスウイルス、形質転換又は感染された細胞、住血吸虫症予防剤及びグルタチオン s−トランスフェラーゼ活性薬剤としての用途
KR870009208A KR880002894A (ko) 1986-08-22 1987-08-22 주혈흡충증왁진으로 사용되는 단백질과 dna 시퀀스
CN198787106696A CN87106696A (zh) 1986-08-22 1987-08-22 蛋白质及其制备方法,adn的顺序,抗体及其用途,痘病病毒,被转化或感染的细胞用于预防血吸虫病的药剂组合物,以及作为谷胱甘肽-s-转移酶活性的显示剂的用途
US07/964,471 US5597570A (en) 1986-08-22 1992-10-21 Protein recognized by antibodies raised against native P28 of schistosoma mansoni

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR878705691A FR2614315B2 (fr) 1987-04-22 1987-04-22 Application de la proteine antigenique p28 a titre d'agent presentant une activite glutathion-s-transferase.

Publications (2)

Publication Number Publication Date
FR2614315A2 FR2614315A2 (fr) 1988-10-28
FR2614315B2 true FR2614315B2 (fr) 1990-04-27

Family

ID=9350370

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878705691A Expired - Lifetime FR2614315B2 (fr) 1986-08-22 1987-04-22 Application de la proteine antigenique p28 a titre d'agent presentant une activite glutathion-s-transferase.

Country Status (1)

Country Link
FR (1) FR2614315B2 (fr)

Also Published As

Publication number Publication date
FR2614315A2 (fr) 1988-10-28

Similar Documents

Publication Publication Date Title
MA21682A1 (fr) Procede de preparation d'agents therapeutiques derives de la quainclidine.
MA24307A1 (fr) Derives d'acides d'arylsulfonylamino-hydroxamiques.
DE68916693T2 (de) Molekular-Diagnose von Alzheimer-Krankheit.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
ATE79135T1 (de) Bifunktionelle proteine.
MX9102701A (es) Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica.
DE3763973D1 (de) Kugelgelenk.
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
FI874828A (fi) Anordning foer lokalisering av stavar inbaeddade i armerad betong med hoeg taethet.
FR2543552B1 (fr) Derives de 3-isoxazolyl-2-imidazolidinone doues d'une activite herbicide
ITMI913465A0 (it) Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano
IT8820935A0 (it) Procedimento per la preparazione di 1,2,5,6,9,10 esabromociclododecano.
DE3862502D1 (de) Kugelgelenk.
IT1230068B (it) Procedimento per la preparazione di n sulfoniluree.
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
FR2614315B2 (fr) Application de la proteine antigenique p28 a titre d'agent presentant une activite glutathion-s-transferase.
NO905327D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.
NO904108L (no) Fremstilling av 2,6-dioksypiperidinderivater.
FR2602233B1 (fr) Derives de l'isoquinoleine
IT8723035A0 (it) Procedimento per la preparazione di n acilaniline.
MX9102364A (es) Metodo de combustion de lecho fluidizado.
MC1816A1 (fr) Derives d'isoquinoleine
MX9203634A (es) Derivados de pirocatecol 3,5-disubstituidos.